These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1750450)

  • 21. Gene Therapy Approaches to Hemoglobinopathies.
    Ferrari G; Cavazzana M; Mavilio F
    Hematol Oncol Clin North Am; 2017 Oct; 31(5):835-852. PubMed ID: 28895851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guidelines for the Standard Monitoring of Patients With Thalassemia: Report of the Thalassemia Longitudinal Cohort.
    Tubman VN; Fung EB; Vogiatzi M; Thompson AA; Rogers ZR; Neufeld EJ; Kwiatkowski JL;
    J Pediatr Hematol Oncol; 2015 Apr; 37(3):e162-9. PubMed ID: 26201037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Globin gene transfer for treatment of the beta-thalassemias and sickle cell disease.
    Sadelain M; Rivella S; Lisowski L; Samakoglu S; Rivière I
    Best Pract Res Clin Haematol; 2004 Sep; 17(3):517-34. PubMed ID: 15498721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Approaches to gene therapy for beta-thalassemia.
    Bank A; Donovan-Peluso M; LaFlamme S; Rund D; Lerner N
    Birth Defects Orig Artic Ser; 1988; 23(5B):339-46. PubMed ID: 3291969
    [No Abstract]   [Full Text] [Related]  

  • 25. Emerging therapy in hemoglobinopathies: lessons from the past and optimism for the future.
    Vichinsky EP
    Hematol Oncol Clin North Am; 2014 Apr; 28(2):xiii-xviii. PubMed ID: 24589274
    [No Abstract]   [Full Text] [Related]  

  • 26. Beta-globin gene disorders in Italy and the Mediterranean area.
    Ottolenghi S; Carestia C
    Horiz Biochem Biophys; 1986; 8():257-98. PubMed ID: 2875932
    [No Abstract]   [Full Text] [Related]  

  • 27. The recombinant human parvoviruses for gene therapy of hemoglobinopathies.
    Dixit M; Tillery MK; Plonk SG; Ohi S
    SAAS Bull Biochem Biotechnol; 1990 Jan; 3():63-8. PubMed ID: 1366418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diagnosis and therapy of hemoglobinopathies].
    Hattori Y
    Nihon Naika Gakkai Zasshi; 1999 Jun; 88(6):1010-5. PubMed ID: 10465943
    [No Abstract]   [Full Text] [Related]  

  • 29. Novel treatment options in the severe beta-globin disorders.
    Rodgers GP; Rachmilewitz EA
    Br J Haematol; 1995 Oct; 91(2):263-8. PubMed ID: 8547060
    [No Abstract]   [Full Text] [Related]  

  • 30. Gene Therapy for β-Hemoglobinopathies.
    Cavazzana M; Antoniani C; Miccio A
    Mol Ther; 2017 May; 25(5):1142-1154. PubMed ID: 28377044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene delivery to human hematopoietic progenitor cells to address inherited defects in the erythroid cellular lineage.
    Strayer DS
    J Hematother Stem Cell Res; 1999 Dec; 8(6):573-4. PubMed ID: 10645762
    [No Abstract]   [Full Text] [Related]  

  • 32. [Population genetics study of hemoglobinopathies in Uzbekistan. II. Population dynamics of hemoglobinopathies].
    Asanov AIu; Ginter EK; Bakhramov SM; Gar'kavtseva RF; Revazov AA
    Genetika; 1987 Jul; 23(7):1328-33. PubMed ID: 2958388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic approaches to hemoglobin switching in treatment of hemoglobinopathies.
    Stamatoyannopoulos JA; Nienhuis AW
    Annu Rev Med; 1992; 43():497-521. PubMed ID: 1374600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thalassemic hemoglobinopathies.
    Steinberg MH; Adams JG
    Am J Pathol; 1983 Dec; 113(3):396-409. PubMed ID: 6359893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of alpha-thalassemia with other hemoglobinopathies in the eastern province of Saudi Arabia.
    Sumer T; Ahmad M; Al-Mouzan M; Al-Awamy B
    Birth Defects Orig Artic Ser; 1987; 23(5A):343-7. PubMed ID: 3689916
    [No Abstract]   [Full Text] [Related]  

  • 36. Globins, from Genes to Physiology and Diseases.
    Vernimmen D
    Blood Cells Mol Dis; 2018 May; 70():1. PubMed ID: 28214138
    [No Abstract]   [Full Text] [Related]  

  • 37. Gene Therapy for beta-thalassemia.
    Malik P; Arumugam PI
    Hematology Am Soc Hematol Educ Program; 2005; ():45-50. PubMed ID: 16304358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Compound heterozygosity of non-deletional hereditary persistence of fetal hemoglobin and deltabeta-thalassemia.
    Kalamaras A; Chassanidis C; Samara M; Papadakis MN; Vagena A; Aleporou-Marinou V; Patrinos GP; Kollia P
    Am J Hematol; 2008 Sep; 83(9):760. PubMed ID: 18615450
    [No Abstract]   [Full Text] [Related]  

  • 39. Recent advance on genome editing for therapy of β-hemoglobinopathies.
    Liu JW; Hong T; Qin X; Liang YM; Zhang P
    Yi Chuan; 2018 Feb; 40(2):95-103. PubMed ID: 29428902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta-globin-gene haplotypes, mitochondrial DNA, the Y-chromosome: their impact on the genetic epidemiology of the major structural hemoglobinopathies.
    Nagel RL
    Cell Mol Biol (Noisy-le-grand); 2004 Feb; 50(1):5-21. PubMed ID: 15040423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.